|
Iosco
County |
P.O. Box 116, Tawas City, MI 48764 www.ioscorepublicans.org e-mail: mail@ioscorepublicans.org
WHAT'S NEW?
For further information on these and previous articles, visit the Archives.
PLEASE CHECK TO SEE IF YOUR DUES ARE CURRENT. IF YOU NEED INFORMATION ON YOUR STATUS, CHECK WITH MAUREEN RUDEL, (989) 362-4747 OR maureen@tawasbay.net
IVERMECTIN'S SURPRISING POTENTIAL AGAINST CANCER
By James Stansbury, September 13, 2025
There is a safe and inexpensive
cure for many types of cancer that is apparently being ignored by medical
industrial complex and media. One possible reason why is because this new
treatment protocol includes ivermectin (IVM). During the pandemic the use of
this so-called “horse dewormer” was vigorously attacked by legacy media and
banned as a COVID-19 treatment by the Biden administration’s FDA and CDC. India
used it and had 10 times fewer deaths. Perhaps admitting that IVM worked would
be embarrassing.
During the pandemic many courageous doctors were fired for questioning the
government-mandated COVID-19 treatment protocol or warning of the dangerous mRNA
vaccine side effects. Undaunted, several of these fired doctors joined forces to
establish the Front Line Covid-19 Critical Care Alliance (FLCCC) to promote IVM
and other repurposed drugs as safe, effective and economical solutions to treat
COVID-19.
As the pandemic subsided, their mission expanded beyond COVID-19. I became aware
of this change in May 2024 because of an Epoch Times video interview featuring
Dr. Kathleen Ruddy, who had partnered with the FLCCC to research some intriguing
evidence that IVM had remarkable potential as a cancer cure.
One case study she mentioned was a patient in late stage 4 prostate cancer near
death. After she convinced him that he had nothing to lose by trying IVM, within
a matter of months he was off his deathbed and back to work. (Joe Biden should
take note). Dr. Ruddy also provided a very likely reason why the use of IVM as a
cancer cure was being ignored. She said “…the pharmaceutical industries were not
going to invest in a $0.10 pill.”
The FLCCC soon changed its name to the Independent Medical Alliance (IMA). Its
new stated mission “is to save lives and promote long-term wellness through
science-based, patient-centered care. Our protocols, widely adopted by
healthcare providers worldwide, are grounded in the latest research and clinical
data, empowering patients to take control of their health.”
Significantly, the IMA also has the science behind how IVM and other repurposed
anti-parasite drugs like Fenbendazole and Mebendazole kill cancer cells. In
addition, the IMA has also identified many other drugs and supplements such as
vitamin D and green tea extract that also have cancer-fighting properties.
Coincidentally these two supplements were also found helpful to treat COVID-19.
The key to understanding how these anti-parasite and other repurposed drugs kill
cancer cells is explained in the IMA’s updated Guide to Stem Cells by Dr. Paul
Marik and Dr. Justus Hope:
“The answer lies with a small population of cells that most standard treatments ignore. Cells that don’t just survive chemotherapy and radiation but adapt and return. They’re called cancer stem cells (CSCs), and they may be the single most overlooked driver of relapse, metastasis, and mortality in cancer care today.” (snip)
“Standard treatment protocols target the fast-dividing cancer cells. CSCs are more resistant and behave differently. They can stay dormant to evade detection, pump drugs out of their system, repair their DNA quickly, thrive in hostile, low-oxygen environments and hijack growth signals from the immune system and surrounding tissue. Adding to the problem, some chemotherapy and radiation protocols may actually stimulate CSCs -- making relapse more likely, not less.” (snip)
"CSCs are biologically wired to survive. They rely on powerful signaling pathways that govern cell survival, repair, and replication. …To beat CSCs, we have to interrupt these signals. The good news is: we can [interrupt them] with repurposed drugs and extremely safe compounds that are widely available."
A more practical document for cancer victims is available in the IMA’s free updated Cancer Care Guide that includes a comprehensive list of repurposed drugs and greater details about which combination of these drugs is best tailored for several different types of cancers (i.e., lung, breast, pancreatic, prostate, stage 4 metastatic diseases, etc.):
“The approach to each patient must be individualized based on the type and stage of the tumor, the tumor biology, the patients’ comorbidities and functional status and the patients’ preferences. Many patients may receive repurposed drugs and metabolic therapy as adjunctive therapy to conventional therapy from an oncologist while others may receive repurposed drugs and metabolic therapy alone. There is no ideal regimen; however, our approach is centered on the primary use of ivermectin, mebendazole, doxycycline and curcumin. It should be recognized that a subset of patients appear to either not respond to ivermectin or respond minimally to the initial ivermectin dose, but MAY respond to higher doses. It is essential that multiple cancer stem cell (CSC) pathways are blocked.”
The IMA cancer guide
includes a disclaimer: “Cancer is a complicated disease, and patient care should
be supervised by an integrative clinician; patients should not treat
themselves.”
I know of no official approval of these treatment protocols by the FDA or CDC.
Therefore, those anticipating surgery, radiation or chemo, may discover that
their current oncologist is not allowed to prescribe any of these repurposed
cancer fighting drugs. However, the IMA homepage has a link titled Resources to
help find a provider or pharmacy in your region.
I’m no medical professional, but did endure radiation for my own prostate cancer
six years ago. It was successful (PSA down to 0.004), but the common side
effects are forever. I can’t help but wonder if the news about IVM had been
known when my PSA number first jumped it may have eliminated the problem before
radiation or surgery became necessary. It would have saved Medicare and Blue
Cross a small fortune too.
I can only hope the IMA’s new cancer treatment protocols have a high priority in
RFK Jr.'s MAHA playbook because Dr. Marik plainly stated that “…despite decades
of research and over $200 billion spent annually, cancer rates continue to
rise.”
Reprinted with permission from the American Thinker: https://www.americanthinker.com
TRUMP'S IMMIGRATION
RESET: H-1AND GOLD CARD ORDERS PUT AMERICA FIRST
By Brian C. Joondeph, September 23, 2025
President Donald Trump’s two
recent executive orders, one imposing a $100,000 annual fee on H-1B visas and
the other launching the “Gold Card” fast-track residency program, represent the
most significant immigration reforms in decades.
They flip the incentive structure that has for years favored multinational
corporations and global outsourcing firms over American workers, while also
tackling long-ignored national security risks.
As a policy, open borders is one area where Democrats and many Republicans
agree. Democrats want new voters, while the Chamber of Commerce and Wall Street
Journal Republicans want cheap labor. President George W. Bush, backed by
Senator John McCain, in 2007, pushed for “comprehensive immigration reform,” a
euphemism for amnesty, for millions of illegal aliens, which fortunately failed
a US Senate vote.
Enter President Trump, the only president in my lifetime who has recognized that
America has a sovereign border. Even President Reagan failed to repair our
dysfunctional immigration system. He signed an amnesty bill into law, which NPR
heralded as “a Reagan legacy,” and it unsurprisingly turned California from a
red to a blue state. No wonder NPR loved it.
The H-1B program was initially created to help U.S. companies fill rare,
high-skilled roles when American expertise was unavailable.
However, in practice, it has become a pathway for cheap foreign labor. According
to the Economic Policy Institute (EPI), in 2022, the top 30 H-1B employers
brought in 34,000 new visa workers even as they laid off at least 85,000
Americans. From MAGA to making the rest of the world great again.
The proportion of IT workers on H-1Bs has risen from 32% in 2003 to over 65%
today, even as unemployment among recent computer science graduates remains
above six percent, according to the White House.
Trump’s order significantly alters the landscape.
Companies now face a $100,000 annual fee per H-1B visa, rather than just a
one-time filing fee, according to the White House. This ongoing expense is meant
to give employers pause. Is the skill truly so scarce that it justifies paying
$100,000 annually to Washington, D.C., in addition to salary and benefits? If
so, that’s acceptable, but the era of flooding payrolls with lower-cost foreign
contractors has ended.
Commerce Secretary Howard Lutnick clarified, “The whole idea is no more with
these big tech companies or other large corporations training foreign workers.
They have to pay the government $100,000, and then they have to pay the
employee.”
To emphasize, this is an annual fee, not a one-time payment. The fee expires
after one year unless renewed.
Perhaps the most damaging effect of the H-1B system has been on young Americans
considering careers in science, technology, engineering, and mathematics. Why
spend years earning a STEM degree, at great personal expense, when companies
like Amazon and Microsoft prefer cheaper contractors from abroad? The White
House itself warned that the H-1B program is creating “disincentives for future
American workers to choose STEM careers.”
That chilling effect has serious consequences. When American graduates see their
job opportunities cut by a surge of imported labor, many choose to leave
critical fields altogether. In the long run, this not only harms wages but also
weakens the nation’s innovation pipeline. Trump’s order restores fair
competition and keeps STEM careers open for U.S. students.
It’s not literal slavery, but it amounts to modern-day indentured servitude with
workers tied to one employer, unable to leave without risking deportation.
The debate extends beyond just economics. Allowing tens of thousands of foreign
nationals, many from strategic competitors like China, to work in sensitive
sectors such as semiconductors, defense, and telecommunications poses serious
national security risks. Intellectual property theft, espionage, and divided
loyalties are real threats, not just theories. They have been repeatedly
documented by U.S. intelligence agencies.
By tightening the H-1B pipeline, Trump’s executive action reduces this exposure.
America cannot afford to have its cutting-edge military and technology sectors
mainly staffed by non-citizens. Conservatives have long argued that border
security and economic security are connected. Trump’s order makes clear that
high-skill visas are no exception.
Ross Perot, when running for president in 1992, famously warned, “You’re going
to hear a giant sucking sound of jobs going south” due to American jobs leaving
the country over NAFTA.
Back then, the threat was factories moving overseas.
Today, the sound is different, but the effect is the same. American workers are
being replaced, this time by imported labor under H-1B. Trump’s reforms respond
to Perot’s warning a generation later by using executive authority to keep jobs
with American citizens.
If the H-1B order closes the cheap-labor loophole, the Gold Card program opens a
new, carefully targeted door.
For a $1 million gift to the U.S. government, wealthy individuals can obtain a
green card through expedited review. Corporations can sponsor key employees for
$2 million, while a proposed Platinum Card at $5 million could someday provide a
path to citizenship. Applicants still must pass background checks and meet
immigration law requirements. The only difference is their position in line,
which they leap to the front.
This approach addresses two issues simultaneously. First, it monetizes
efficiency by having applicants pay for expedited processing instead of
taxpayers funding an overcrowded immigration system. Second, it makes sure that
those who skip ahead are likely to be job creators and investors, not
liabilities. As CBS News reported, Trump explained: “We’re going to have great
people coming in, and they’re going to be paying.”
Such programs are common. Portugal offers a Golden Visa program that requires a
five-year investment in monetary assets for residency, which is less direct and
efficient compared to Trump’s proposal.
For conservatives cautious about unrestricted immigration, this presents a
strong bargain: America gains capital instead of bearing costs.
Unsurprisingly, Big Tech is unhappy. Venture capitalists argue that the $100,000
H-1B fee could hurt America’s competitiveness, but this overlooks how the
current system has suppressed domestic innovation by discouraging Americans from
pursuing STEM careers. Genuine innovation thrives when American students and
workers believe they can compete fairly.
Foreign governments have also expressed concern, especially India, which depends
heavily on exporting workers to the U.S.
However, “mutual benefits” cannot mean ongoing disadvantages for American
workers. If Indian talent is truly essential, companies can pay higher fees or
opt for the Gold Card route.
These executive orders achieve what years of congressional debate failed to do
-- they restore fairness and balance. They send a clear message that American
jobs and national security come first, while still welcoming genuine talent and
investment. This is true MAGA.
Critics might question the legality of Trump’s actions, and courts could
intervene. Some far-left judges are probably already preparing their restraining
orders and injunctions. But Trump is not changing immigration law itself, only
the process, which is controlled by the executive branch.
The political message is clear. Under this administration, immigration policy is
no longer aimed at boosting corporate profits or appeasing foreign governments.
Instead, it is focused on defending the American worker, supporting the American
student, and securing America’s future.
Contrast this with the Biden administration, which has allowed record levels of
illegal border crossings. Trump has sealed the border and is now fixing a broken
immigration system.
President Trump’s dual actions on immigration, the H-1B overhaul and the Gold
Card launch, are bold, controversial, and exactly what conservatives have
demanded for years.
By making H-1Bs prohibitively expensive each year, he fights wage suppression,
encourages Americans to pursue STEM fields, and addresses national security
concerns. Simultaneously, the Gold Card provides a practical, revenue-generating
pathway for the world’s most talented entrepreneurs and investors to come to
America legally.
This is what immigration policy should be -- tough, fair, and unapologetically
MAGA pro-American.
Brian C. Joondeph, M.D., is a physician and writer. Follow me on Twitter @retinaldoctor,
Substack Dr. Brian’s Substack, Truth Social @BrianJoondeph, LinkedIn @Brian
Joondeph, and by email
brianjoondeph@gmail.com.
Reprinted with permission from the American Thinker: https://www.americanthinker.com
SUNRISE SIDE REPUBLICANS WOMEN'S CLUB
The Sunrise Side Republican
Women's
Club holds monthly meetings on the 4th Tuesday of the
month. The location and speaker will be announced for each meeting.
Unless otherwise stated, the lunch will be at 11:30 a.m.
The officers are: Jane Hayward, President, 989-739-3126 Roxanne Rosenfeld, Vice President, 989-362-1259, Amy Merrick, Secretary, 989-747-0479 and Mary Riley, Treasurer, 989-305-6302.
The SSRWC next meeting will be
You can send correspondence to
MEETING -- Tuesday, November 11, 2025 at 7:00 p.m.
Maureen Rudel's House, 910 E. Bay St. (US 23), East Tawas
All Republicans are welcome to attend and contribute their thoughts to our discussions.
CHECK OUT OUR WEBSITE: http://www.ioscorepublicans.org
E-MAIL ADDRESS: mail@ioscorepublicans.org
US Senate Switchboard --202-224-3121.
US House
switchboard: 202-225-3121
DO YOU LIKE THE NEWSLETTER?
Even if you're not quite ready to "join" the Party, we would appreciate a donation to help offset the costs of sending this to you. . .
SOUND OFF!!
If you have an issue which you believe should be addressed, write us or send us an e-mail -- mail@ioscorepublicans.org. We have incorporated a Guest Column Section on the Web Site and in the newsletter. We will publish your opinion or letter if you sign it, give an address and phone number (so we can make sure you wrote it -- we won't publish it unless you specifically request it). Short, sweet and to the point. We reserve the right to edit all letters.
Check the Meeting Page for more information on upcoming activities.
To View Additional Information From Prior What's New Pages,